Detalles de la búsqueda
1.
Health-related quality of life in patients with steroid-refractory acute graft-versus-host disease.
Eur J Haematol
; 111(2): 240-246, 2023 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-37137484
2.
Estimating Quality of Life Decrements in Oncology Using Time to Death.
Value Health
; 25(10): 1673-1677, 2022 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-35803844
3.
Real-world evidence in health technology assessment of high-risk medical devices: Fit for purpose?
Health Econ
; 31 Suppl 1: 10-24, 2022 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-35989520
4.
Variation in the utilization of medical devices across Germany, Italy, and the Netherlands: A multilevel approach.
Health Econ
; 31 Suppl 1: 135-156, 2022 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-35398955
5.
Do existing real-world data sources generate suitable evidence for the HTA of medical devices in Europe? Mapping and critical appraisal.
Int J Technol Assess Health Care
; 37(1): e62, 2021 Apr 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-33896433
6.
Assessment of Studies Evaluating Incremental Costs, Effectiveness, or Cost-Effectiveness of Systemic Therapies in Breast Cancer Based on Claims Data: A Systematic Review.
Value Health
; 23(11): 1497-1508, 2020 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-33127021
7.
Cost of health care for paediatric patients with sickle cell disease: An analysis of resource use and costs in a European country.
Pediatr Blood Cancer
; 67(9): e28588, 2020 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-32672889
8.
Cost-effectiveness: maximizing impact by meticulous data.
Blood
; 140(6): 525-526, 2022 08 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-35951343
9.
Efficacy of first-line treatments for multiple myeloma patients not eligible for stem cell transplantation: a network meta-analysis.
Haematologica
; 104(5): 1026-1035, 2019 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-30606791
10.
Second-line treatment for acute graft-versus-host disease with mesenchymal stromal cells: A decision model.
Eur J Haematol
; 2018 Aug 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-30084111
11.
Balancing the Optimal and the Feasible: A Practical Guide for Setting Up Patient Registries for the Collection of Real-World Data for Health Care Decision Making Based on Dutch Experiences.
Value Health
; 20(4): 627-636, 2017 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-28408005
12.
A cost-effectiveness analysis of real-world treatment for elderly patients with multiple myeloma using a full disease model.
Eur J Haematol
; 96(2): 198-208, 2016 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-25892333
13.
Cost-effectiveness of rituximab as maintenance treatment for relapsed follicular lymphoma: results of a population-based study.
Eur J Haematol
; 92(5): 398-406, 2014.
Artículo
en Inglés
| MEDLINE | ID: mdl-24400940
14.
Policymaker, please consider your needs carefully: does outcomes research in relapsed or refractory multiple myeloma reduce policymaker uncertainty regarding value for money of bortezomib?
Value Health
; 17(2): 245-53, 2014 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-24636383
15.
Changes in income and employment after diagnosis among patients with multiple myeloma in The Netherlands.
Clin Lymphoma Myeloma Leuk
; 2024 Apr 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-38724440
16.
Regulatory Approval, Reimbursement, and Clinical Use of Cyclin-Dependent Kinase 4/6 Inhibitors in Metastatic Breast Cancer in the Netherlands.
JAMA Netw Open
; 6(2): e2256170, 2023 Feb 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36795415
17.
Costs of Newly Funded Proton Therapy Using Time-Driven Activity-Based Costing in The Netherlands.
Cancers (Basel)
; 15(2)2023 Jan 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-36672465
18.
Cost-Effectiveness of Abemaciclib in Early Breast Cancer Patients: One Size Fits All or Tailoring to Patients' Needs?
Breast Cancer (Dove Med Press)
; 15: 147-161, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-36814469
19.
Cost-Effectiveness Analysis of MammaPrint® to Guide the Use of Endocrine Therapy in Patients with Early-Stage Breast Cancer.
Pharmacoeconomics
; 41(8): 981-997, 2023 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-37245167
20.
Changes in survival in de novo metastatic cancer in an era of new medicines.
J Natl Cancer Inst
; 115(6): 628-635, 2023 06 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-36978244